health
How IHH Healthcare CEO Prem Kumar Nair is planning for a longer-lived Asia
“There’s no point in living longer if you’re not healthy.”
TL;DR
- Asia's population is aging, leading to increased wealth, longer lifespans, and a greater willingness to spend on health.
- Lifestyle diseases like diabetes, hypertension, and high cholesterol are on the rise due to increased affluence and changing lifestyles.
- IHH Healthcare has launched 'Healthspan,' a preventive health and longevity program focusing on clinical intervention rather than aesthetics.
- The company is expanding its healthcare ecosystem by building ambulatory care centers in dense urban areas.
- IHH Healthcare is shifting focus from acquisitions to organic growth within its existing markets.
- The COVID-19 pandemic highlighted the need for public and private sector collaboration in healthcare.
- IHH Healthcare is diversifying its presence across multiple countries to hedge against market volatility.
- Cancer is emerging as the biggest subspecialty in IHH hospitals, leading to investments in cancer testing, genomic medicine, and precision medicine.
- IHH Healthcare is investing in AI-enabled solutions, including AI-driven clinical pathways and automation tools like NurseShift.ai.
- The company is nurturing health start-ups through its IHH Catalyst program.